audiological evaluation of patients taking kanamycin for multidrug resistant tuberculosis

نویسندگان

vishal sharma department of otorhinolaryngology, government medical college, patiala, punjab, india.

sanjeev bhagat department of otorhinolaryngology, government medical college, patiala, punjab, india.

ravinder singh department of otorhinolaryngology, government medical college, patiala, punjab, india.

bhimsain verma department of otorhinolaryngology, government medical college, patiala, punjab, india.

چکیده

introduction: the incidence of multidrug resistant tuberculosis is increasing in developing countries. aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. this study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for multidrug resistant tuberculosis (mdr-tb), kanamycin, at a government medical college, patiala, punjab, india, which is a 1200 bed tertiary care hospital.  materials and methods: a total of 100 patients (68 males and 32 females) with confirmed diagnosis of mdr-tb were included in this study conducted between january 2012 and february 2014. subjects were between 15 to 60 years of age, with a mean age of 37.46 ± 10.1. pure tone audiometry (pta) was performed before the start of the therapy, as a baseline, and was repeated after 1 week and 6 weeks of kanamycin use to assess hearing loss as an effect of therapy.  results: of the 100 patients examined, ototoxicity was found in 18 subjects post therapy. incidence of high frequency hearing loss was 2% at week 1, and 12% after 6 weeks of follow up. however, 4% of the cases developed flat loss at week 6. the hearing loss was bilateral in 13 patients and unilateral in 5 patients. ototoxicity was more common in males (66.67%) compared to females (33.3%). maximum cases were found in the age group of 36 to 45 years (36.8%), the majority being from a rural background (83.3%). the association with socioeconomic status (p=0.024) and co-morbid conditions like diabetes and hypertension (p=0.001) reached statistical significance.  conclusion:  lack of specific guidelines to monitor patients taking aminoglycosides makes ototoxicity a major adverse effect of their use in mdr-tb. more studies are mandated to study the risk factors associated with the development of ototoxicity and for the development of alternate drugs for the treatment of mdr-tb.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis

Introduction: The incidence of multidrug resistant tuberculosis is increasing in developing countries. Aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. This study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for Multidrug resistant tuberculosis (MDR-TB), Kanamycin, at a Gov...

متن کامل

Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis

INTRODUCTION The incidence of multidrug resistant tuberculosis is increasing in developing countries. Aminoglycosides are an integral part of second-line drugs, however ototoxicity is a major limitation for their use. This study aims to determine the extent of hearing loss in patients taking one of the commonly prescribed drugs for Multidrug resistant tuberculosis (MDR-TB), Kanamycin, at a Gove...

متن کامل

The Incidence of Amikacin Ototoxicity in Multidrug-Resistant Tuberculosis Patients

Amikacin has been shown to irreversibly suppressCochlear activity.The aim of this study is to assess the incidence of amikacinototoxicity in multidrug-resistant tuberculosis patients and riskfactors associated withthis ototoxicity.In this cross-sectional study, 41 patientswith multidrug-resistant tuberculosis (MDR-TB) were included.All patients received fixed dose of intravenous amikacin(500 mg...

متن کامل

The Incidence of Amikacin Ototoxicity in Multidrug-Resistant Tuberculosis Patients

Amikacin has been shown to irreversibly suppressCochlear activity.The aim of this study is to assess the incidence of amikacinototoxicity in multidrug-resistant tuberculosis patients and riskfactors associated withthis ototoxicity.In this cross-sectional study, 41 patientswith multidrug-resistant tuberculosis (MDR-TB) were included.All patients received fixed dose of intravenous amikacin(500 mg...

متن کامل

Study of HIV seroprevalence in Pulmonary Tuberculosis Patients with Special Reference to Multidrug Resistant Mycobacteria

This study was planned to determine HIV seroprevalence among pulmonary tuberculosis patients, to characterize the isolated mycobacteria into typical and atypical strains and to evaluate the drug resistant pattern of mycobacterial isolates. The study aims to correlate multidrug resistance (MDR) and HIV seropositivity status in pulmonary tuberculosis patients. During the year 1994-1997, 750 pulmo...

متن کامل

Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients.

STUDY OBJECTIVES Therapeutic drug monitoring (TDM) is the process of obtaining the serum concentration of a medication and modifying the dose based on the results. Little is known about the application of TDM in the treatment of patients with multidrug-resistant (MDR) tuberculosis (TB) in clinical practice. This study characterized how TDM was applied in the management of MDR TB patients, and e...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of otorhinolaryngology

جلد ۲۸، شماره ۳، صفحات ۲۰۳-۲۰۸

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023